Related Experiment Video
Updated: Jun 28, 2025

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
Published on: May 10, 2021
Atorvastatin reduces calcification in valve interstitial cells via the NF-κB signalling pathway by promoting
1Department of Surgery, Hebei Medical University, Shijiazhuang, Hebei; Department of Cardiothoracic Surgery, The Third Hospital of Shijiazhuang, Hebei. cpeb17@163.com.
Insights
Atorvastatin inhibits aortic valve calcification (AVC) by enhancing autophagy and suppressing the NF-κB pathway. This study reveals a novel mechanism for atorvastatin in treating this common cardiovascular disease.
Area of Science:
- Cardiovascular Research
- Cell Biology
- Pharmacology
Background:
- Aortic valve calcification (AVC) is a prevalent cardiovascular condition and a significant risk factor for sudden death.
- Understanding the underlying mechanisms and identifying effective therapeutic agents for AVC remain critical research areas.
- Atorvastatin, a cholesterol-lowering statin, shows potential for cardiovascular event prevention, but its specific effects and mechanisms on AVC require further investigation.
Purpose of the Study:
- To explore the potential of atorvastatin in inhibiting in vitro aortic valve calcification (AVC).
- To elucidate the underlying cellular and molecular mechanisms by which atorvastatin may affect AVC.
- To investigate the role of autophagy and the NF-κB signaling pathway in atorvastatin's effects on valve interstitial cells.
Main Methods:
- Development of an in vitro model of aortic valve calcification (AVC) using valve interstitial cells.
- Treatment of calcified valve interstitial cells with atorvastatin.
- Assessment of osteogenic differentiation and calcium nodule deposition.
- Analysis of autophagy markers (Atg5, LC3B-II/I) and autophagic flow.
- Investigation of the NF-κB signaling pathway and associated inflammatory factors.
Main Results:
- Atorvastatin significantly inhibited osteogenic differentiation and reduced calcium nodule deposition in valve interstitial cells.
- Atorvastatin enhanced autophagy in calcified valve interstitial cells, evidenced by increased Atg5 and LC3B-II/I expression and improved autophagic flow.
- Atorvastatin suppressed the NF-κB signaling pathway and NF-κB-mediated inflammatory factor expression.
- Activation of the NF-κB pathway reversed the beneficial effects of atorvastatin on autophagy and valve interstitial cell calcification.
Conclusions:
- Atorvastatin alleviates aortic valve calcification (AVC) by upregulating autophagy and inhibiting the NF-κB signaling pathway.
- The findings suggest that atorvastatin's mechanism involves promoting autophagic flux, which counteracts the pro-calcification effects mediated by the NF-κB pathway.
- This study provides a mechanistic basis for atorvastatin's potential therapeutic role in managing AVC.
Abstract:
Aortic valve calcification (AVC) is a common cardiovascular disease and a risk factor for sudden death. However, the potential mechanisms and effective therapeutic drugs need to be explored. Atorvastatin is a statin that can effectively prevent cardiovascular events by lowering cholesterol levels. However, whether atorvastatin can inhibit AVC by reducing low-density lipoprotein (LDL) and its possible mechanism of action require further exploration. In the current study, we constructed an in vitro AVC model by inducing calcification of the valve interstitial cells. We found that atorvastatin significantly inhibited osteogenic differentiation, reduced the deposition of calcium nodules in valve interstitial cells, and enhanced autophagy in calcified valve interstitial cells, manifested by increased expression levels of the autophagy proteins Atg5 and LC3B-II/I and the formation of smooth autophagic flow. Atorvastatin inhibited the NF-κB signalling pathway and the expression of inflammatory factors mediated by NF-κB in calcified valve interstitial cells. The activation of the NF-κB signalling pathway led to the reversal of atorvastatin's effect on enhancing autophagy and alleviating valve interstitial cell calcification. In conclusion, atorvastatin inhibited the NF-κB signalling pathway by upregulating autophagy, thereby alleviating valve interstitial cell calcification, which was conducive to improving AVC.
More Related Videos
08:55Isolation and Characterization of Primary Rat Valve Interstitial Cells: A New Model to Study Aortic Valve Calcification
Published on: November 20, 2017
04:30Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Antihypertensive Drugs: Action of Calcium Channel Blockers
Regulation of Nuclear Protein Sorting
Intracellular Signaling Affects Focal Adhesions
Some...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The Extrinsic Apoptotic Pathway